# | Title | Journal | Year | Citations |
---|
1 | HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors | Journal of NeuroVirology | 2011 | 1,327 |
2 | Analysis Of Htlv-I Proviral Load In 202 Ham/Tsp Patients And 243 Asymptomatic Htlv-I Carriers: High Proviral Load Strongly Predisposes To Ham/Tsp | Journal of NeuroVirology | 1998 | 711 |
3 | HIV-associated cognitive impairment before and after the advent of combination therapy | Journal of NeuroVirology | 2002 | 555 |
4 | Blood-brain barrier biology and methodology | Journal of NeuroVirology | 1999 | 402 |
5 | Human Immunodeficiency Virus-Associated Dementia: An Evolving Disease | Journal of NeuroVirology | 2003 | 370 |
6 | HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings | Journal of NeuroVirology | 1995 | 369 |
7 | The Epidemiology of Human Immunodeficiency Virus-Associated Neurological Disease in the Era of Highly Active Antiretroviral Therapy | Journal of NeuroVirology | 2002 | 354 |
8 | CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection | Journal of NeuroVirology | 2001 | 351 |
9 | Progressive Multifocal Leukoencephalopathy in Patients with HIV Infection | Journal of NeuroVirology | 1998 | 340 |
10 | Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus–infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: A combined study of two cohorts Clinical Report | Journal of NeuroVirology | 2004 | 330 |
11 | Chemokine and chemokine receptor expression in the central nervous system | Journal of NeuroVirology | 1999 | 274 |
12 | Rabies virus receptors | Journal of NeuroVirology | 2005 | 259 |
13 | Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease | Journal of NeuroVirology | 1999 | 258 |
14 | Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare | Journal of NeuroVirology | 1995 | 247 |
15 | Antiretroviral neurotoxicity | Journal of NeuroVirology | 2012 | 234 |
16 | Local Neuroinflammation and the Progression of Alzheimer's Disease | Journal of NeuroVirology | 2002 | 225 |
17 | Detection of the human immunodeficiency virus regulatory proteintatin CNS tissues | Journal of NeuroVirology | 2000 | 217 |
18 | Infections of the central nervous system of suspected viral origin: A collaborative study from Finland | Journal of NeuroVirology | 2001 | 200 |
19 | Autistic disorder and viral infections | Journal of NeuroVirology | 2005 | 196 |
20 | Neuronal apoptosis induced by HIV-1 Tat protein and TNF-α: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia | Journal of NeuroVirology | 1998 | 188 |
21 | Olfactory transmission of neurotropic viruses | Journal of NeuroVirology | 2005 | 180 |
22 | Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues | Journal of NeuroVirology | 2006 | 179 |
23 | Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era | Journal of NeuroVirology | 2010 | 179 |
24 | Enteroviruses as agents of emerging infectious diseases | Journal of NeuroVirology | 2005 | 178 |
25 | Chemokines and chemokine receptors in CNS pathology | Journal of NeuroVirology | 1999 | 176 |
26 | Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy | Journal of NeuroVirology | 2009 | 176 |
27 | Acceleration of HIV dementia with methamphetamine and cocaine | Journal of NeuroVirology | 2001 | 169 |
28 | Robust expression of TNFa, IL-1ß, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus | Journal of NeuroVirology | 2001 | 167 |
29 | Detection of Herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction | Journal of NeuroVirology | 1996 | 166 |
30 | Cytokine regulation of CC and CXC chemokine expression by human astrocytes | Journal of NeuroVirology | 1999 | 165 |
31 | Central nervous system infections in individuals with HIV-1 infection | Journal of NeuroVirology | 2002 | 161 |
32 | COVID-19 and the nervous system | Journal of NeuroVirology | 2020 | 161 |
33 | The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target | Journal of NeuroVirology | 1998 | 159 |
34 | Brain mitochondrial injury in human immunodeficiency virus–seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors | Journal of NeuroVirology | 2005 | 158 |
35 | Clinical factors related to brain structure in HIV: the CHARTER study | Journal of NeuroVirology | 2011 | 158 |
36 | Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer’s disease | Journal of NeuroVirology | 2019 | 158 |
37 | Clinical Epidemiology and Survival of Progressive Multifocal Leukoencephalopathy in the Era of Highly Active Antiretroviral Therapy: Data from the Italian Registry Investigative Neuro AIDS (IRINA) | Journal of NeuroVirology | 2003 | 157 |
38 | Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system | Journal of NeuroVirology | 2014 | 151 |
39 | Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus | Journal of NeuroVirology | 2014 | 151 |
40 | Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures | Journal of NeuroVirology | 1997 | 150 |
41 | Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/microglia and intrathecal immune activation | Journal of NeuroVirology | 1996 | 148 |
42 | Pathogenesis of Human Immunodeficiency Virus-Induced Neurological Disease | Journal of NeuroVirology | 2003 | 148 |
43 | Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression | Journal of NeuroVirology | 2011 | 147 |
44 | Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders | Journal of NeuroVirology | 1999 | 146 |
45 | Pathogenesis of mouse hepatitis virus-induced demyelination | Journal of NeuroVirology | 1996 | 145 |
46 | HIV-1 target cells in the CNS | Journal of NeuroVirology | 2015 | 141 |
47 | Immortalization of primary microglia: a new platform to study HIV regulation in the central nervous system | Journal of NeuroVirology | 2017 | 140 |
48 | Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy | Journal of NeuroVirology | 2000 | 138 |
49 | A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes | Journal of NeuroVirology | 2013 | 138 |
50 | Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains | Journal of NeuroVirology | 2009 | 136 |